Related Experiment Video
Updated: Jun 1, 2026
09:18
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
[New options for pancreatic cancer diagnostics]
J Kat'uchová1, J Bober, P Harbul'ák
1I. Chirurgická klinika LF UPJS a UNLP Kosice, Slovenská republika. jana.katuchova@upjs.sk
Summary
Pancreatic cancer survival rates are poor. Immunohistochemical examination of lymph nodes can identify early-stage pancreatic cancer patients, improving diagnostic capabilities and patient outcomes.
Area of Science:
- Oncology
- Surgical Pathology
- Diagnostic Imaging
Context:
- Pancreatic cancer has a dismal 5-year survival rate (5-15%).
- Early detection is crucial for improving patient outcomes.
- Current diagnostic methods may not sufficiently identify all early-stage disease.
Purpose:
- To evaluate the utility of immunohistochemical examination of lymph nodes in identifying early-stage pancreatic cancer.
- To compare survival rates between different patient cohorts and stages of pancreatic cancer.
- To assess the effectiveness of advanced histopathological techniques in pancreatic cancer diagnosis.
Summary:
- A comparative study analyzed pancreatic cancer patients operated between 1996-2000 (Group A) and 2005-2009 (Group B).
- Survival rates were compared, with Group A showing 6.8% 5-year survival and Group B showing no 5-year survivors.
- Immunohistochemical examination of histopathologically negative lymph nodes revealed positive nodes in 6 out of 108 patients treated between 2007-2009, indicating potential for early detection.
Impact:
- Immunohistochemistry can detect micrometastases in lymph nodes, aiding in the identification of early-stage pancreatic cancer.
- This technique enhances diagnostic accuracy and may lead to earlier intervention for eligible patients.
- Improved identification of early-stage pancreatic cancer patients can potentially improve overall survival statistics.
